Cargando...
FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
Acute Myeloid Leukaemia (AML) is a blood cancer, which affects the red blood cells in the bone marrow. Of the possible proteins that are affected in AML, fms-like tyrosine kinase 3 (FLT3) has long been recognized as a potential therapeutic target as it affects the other signaling pathways and leads...
Guardado en:
| Publicado en: | Bioinformation |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Biomedical Informatics
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677903/ https://ncbi.nlm.nih.gov/pubmed/31435156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015104 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|